TAMPA, Fla. – Moffitt Cancer Center has updated its leadership structure to accommodate its continued substantial growth and to adapt and thrive in a challenging environment.
- Yvette Tremonti: Tremonti is assuming the role of executive vice president of Strategy and Business Development. She will oversee Planning, Strategic Alliances, Public Relations & Marketing, Board Relations, the Board of Advisors, Moffitt Diversity and Human Resources. Tremonti will assume the role previously held by Nick Porter, who will retire in March after 23 years with the cancer center.
- Jack Kolosky: Kolosky, executive vice president/chief operating officer, is also the new president of the Hospital Corporation.
- James Mulé: Mulé, Ph.D., will assume responsibility for Translational Research as the new associate center director and will be the strategic liaison leading the proactive effort to bridge basic to clinical research opportunities.
About Moffitt Cancer Center
Located in Tampa, Florida, Moffitt Cancer Center is an NCI Comprehensive Cancer Center - a designation that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 14 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.